Acquired Gitelman Syndrome in an Anti-SSA Antibody-positive Patient with a SLC12A3 Heterozygous Mutation

Intern Med. 2016;55(21):3201-3204. doi: 10.2169/internalmedicine.55.6390. Epub 2016 Nov 1.

Abstract

A 36-year-old woman developed hypokalemic metabolic alkalosis after anti SS-A antibody was found to be positive. Diuretic loading test results were compatible with Gitelman syndrome (GS). The patient had a heterozygous mutation in SLC12A3, which encodes for thiazide-sensitive NaCl cotransporter (NCCT). While the mutation may be responsible for a latent hypofunction of NCCTs, the underlying anti-SSA antibody-associated autoimmunity induced the manifestation of its hypofunction. To the best of our knowledge, this is the first report to demonstrate that anti SS-A antibody-associated autoimmunity may induce GS in a patient with a SLC12A3 heterozygous mutation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Antinuclear / blood
  • Diagnosis, Differential
  • Female
  • Genetic Predisposition to Disease
  • Gitelman Syndrome / blood
  • Gitelman Syndrome / diagnosis*
  • Gitelman Syndrome / genetics
  • Humans
  • Solute Carrier Family 12, Member 3 / genetics*

Substances

  • Antibodies, Antinuclear
  • SLC12A3 protein, human
  • SS-A antibodies
  • Solute Carrier Family 12, Member 3